Similarly, tissue-specific targeting via the epidermal growth factor receptor (EGFR) [94], or via a tumour marker like melanoma-associated high molecular weight antigen [95], have been developed with the assistance of dimeric antibody fragments (diabodies) [96]. The gene discussed is EGFR; the disease is melanoma.